In our study, we provide an overview of ANLN’s roles in pan-cancer, which includes gene expression, prognostic value, molecular mechanisms, immunological roles, predictive value, and tumor heterogeneity, indicating that ANLN is a potential therapeutic biomarker for malignancies. This evidence concerns the gene ANLN and neoplasm.